Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing (A57290) - R4 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Proteomics Testing (A59642) - R11 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Repeat Germline Testing (A57332) - R18 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R25 - Effective October 1, 2025 Oct 23, 2025
Multiple LCDs and Billing and Coding Articles Retirement - Effective October 23, 2025 Oct 23, 2025
Billing and Coding: Zika Virus Testing by PCR and ELISA Methods (A55327) - R12 - Effective October 01, 2022 Oct 16, 2025
MolDX: DecisionDx-UM (Uveal Melanoma) (L37072) - R7 - Effective June 30, 2022 Oct 16, 2025
MolDX: Prometheus IBD sgi Diagnostic Policy (L37313) - R9 - Effective March 13, 2025 Oct 16, 2025
MDS FISH (L37622) - R6 - Effective June 30, 2022 Oct 16, 2025
MolDX: Melanoma Risk Stratification Molecular Testing (L37748) - R8 - Effective June 26, 2025 Oct 16, 2025
Multiple LCDs and Billing and Coding Articles Retirement - Effective October 16, 2025 Oct 16, 2025
Billing and Coding: Routine Foot Care (A57957) - R16 - Effective October 1, 2025 Oct 16, 2025
Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) (L39812) - R2 - Effective April 17, 2025 Oct 09, 2025
ProMark Risk Score (L36706) - R6 - Effective December 30, 2021 Oct 09, 2025
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (L39927) - R2 - Effective August 17, 2025 Oct 09, 2025
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (L39003) - R5 - Effective July 3, 2025 Oct 09, 2025
MolDX: Molecular Diagnostic Tests (MDT) (L36256) - R16 - Effective May 5, 2025 Oct 09, 2025
MolDX: NRAS Genetic Testing (L36339) - R8 - Effective July 23, 2023 Oct 09, 2025
MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma (L39594) - R8 - Effective August 18, 2024 Oct 09, 2025
MolDX: Minimal Residual Disease Testing for Cancer (L38816) - R1 - Effective January 2, 2022 Oct 09, 2025